FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119153085> ?p ?o ?g. }

• W3119153085 endingPage "155428" @default.
• W3119153085 startingPage "155428" @default.
• W3119153085 abstract "Accumulating evidence supports that the viral-induced hyper-inflammatory immune response plays a central role in COVID-19 pathogenesis. It might be involved in the progression to acute respiratory distress syndrome (ARDS), multi-organ failure leading to death. In this study, we aimed to evaluate the prognostic value of the immune-inflammatory biomarkers in COVID-19, then determine optimal thresholds for assessing severe and fatal forms of this disease.153 patients with confirmed COVID-19 were included in this study, and classified into non-severe and severe groups. Plasmatic levels of interleukin 6 (IL6), C-reactive protein (CRP), soluble-IL2 receptor (IL2Rα), procalcitonin (PCT) and ferritin were measured using chemiluminescence assay. Complete blood count was performed by Convergys 3X® hematology analyzer. Our results demonstrated that the peripheral blood levels of IL6, PCT, CRP, ferritin, IL2Rα, white blood cell count (WBC), neutrophil count (NEU), neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (d-NLR) were significantly higher in severe forms of COVID-19. The ROC curve analysis showed that IL6 was the most accurate inflammatory biomarker. The calculated cutoff of IL6 (42 pg/ml) could correctly classify > 90% of patients regarding their risk of severity (area under ROC curve (AUROC) = 0.972) and the threshold value of 83 pg/ml was highly predictive of the progression to death (AUROC = 0.94, OR = 184) after a median of 3 days. Besides, IL-6 was positively correlated with other inflammatory markers and the kinetic analysis highlighted its value for monitoring COVID-19 patients. PCT and NLR had also a high prognostic relevance to assess severe forms of COVID-19 with corresponding AUROC of 0.856, 0.831 respectively. Furthermore the cut-off values of PCT (0.16 ng/ml) and NLR (7.4) allowed to predict mortality with high accuracy (se = 96.3%, sp = 70.5%,OR = 61.2)’ (se = 75%, sp = 84%, OR = 14.6).The levels of these parameters were not influenced by corticosteroid treatment, which make them potential prognostic markers when patients are already undergoing steroid therapy." @default.
• W3119153085 created "2021-01-18" @default.
• W3119153085 creator A5002462389 @default.
• W3119153085 creator A5004594523 @default.
• W3119153085 creator A5007555318 @default.
• W3119153085 creator A5021628655 @default.
• W3119153085 creator A5029961005 @default.
• W3119153085 creator A5036153522 @default.
• W3119153085 creator A5038663308 @default.
• W3119153085 creator A5045732038 @default.
• W3119153085 creator A5049522204 @default.
• W3119153085 creator A5056313787 @default.
• W3119153085 creator A5057925637 @default.
• W3119153085 creator A5060832702 @default.
• W3119153085 creator A5062969365 @default.
• W3119153085 creator A5068144638 @default.
• W3119153085 creator A5068872213 @default.
• W3119153085 creator A5069343639 @default.
• W3119153085 creator A5071302751 @default.
• W3119153085 creator A5071921752 @default.
• W3119153085 creator A5072894293 @default.
• W3119153085 creator A5073226510 @default.
• W3119153085 creator A5079277645 @default.
• W3119153085 creator A5079305498 @default.
• W3119153085 creator A5082431438 @default.
• W3119153085 creator A5087703088 @default.
• W3119153085 creator A5089586433 @default.
• W3119153085 date "2021-05-01" @default.
• W3119153085 modified "2023-10-01" @default.
• W3119153085 title "Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19" @default.
• W3119153085 cites W2124519382 @default.
• W3119153085 cites W2140500533 @default.
• W3119153085 cites W2148658155 @default.
• W3119153085 cites W2515625652 @default.
• W3119153085 cites W2811133479 @default.
• W3119153085 cites W2894810674 @default.
• W3119153085 cites W2990691157 @default.
• W3119153085 cites W3001118548 @default.
• W3119153085 cites W3006480846 @default.
• W3119153085 cites W3007940623 @default.
• W3119153085 cites W3008827533 @default.
• W3119153085 cites W3009314935 @default.
• W3119153085 cites W3009859788 @default.
• W3119153085 cites W3009885589 @default.
• W3119153085 cites W3009898265 @default.
• W3119153085 cites W3009917784 @default.
• W3119153085 cites W3009992310 @default.
• W3119153085 cites W3010592738 @default.
• W3119153085 cites W3011152298 @default.
• W3119153085 cites W3012339747 @default.
• W3119153085 cites W3012422150 @default.
• W3119153085 cites W3012696170 @default.
• W3119153085 cites W3012849736 @default.
• W3119153085 cites W3014003872 @default.
• W3119153085 cites W3015544049 @default.
• W3119153085 cites W3016124709 @default.
• W3119153085 cites W3016661132 @default.
• W3119153085 cites W3016987930 @default.
• W3119153085 cites W3017287557 @default.
• W3119153085 cites W3018868982 @default.
• W3119153085 cites W3019187481 @default.
• W3119153085 cites W3019785070 @default.
• W3119153085 cites W3023060302 @default.
• W3119153085 cites W3025063365 @default.
• W3119153085 cites W3025160648 @default.
• W3119153085 cites W3027456712 @default.
• W3119153085 cites W3031621442 @default.
• W3119153085 cites W3032533580 @default.
• W3119153085 cites W3032543466 @default.
• W3119153085 cites W3034168389 @default.
• W3119153085 cites W3035340743 @default.
• W3119153085 cites W3036850492 @default.
• W3119153085 cites W3041206342 @default.
• W3119153085 cites W3087151262 @default.
• W3119153085 cites W3110774801 @default.
• W3119153085 cites W3116888444 @default.
• W3119153085 cites W744635124 @default.
• W3119153085 doi "https://doi.org/10.1016/j.cyto.2021.155428" @default.
• W3119153085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7834734" @default.
• W3119153085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33550165" @default.
• W3119153085 hasPublicationYear "2021" @default.
• W3119153085 type Work @default.
• W3119153085 sameAs 3119153085 @default.
• W3119153085 citedByCount "47" @default.
• W3119153085 countsByYear W31191530852021 @default.
• W3119153085 countsByYear W31191530852022 @default.
• W3119153085 countsByYear W31191530852023 @default.
• W3119153085 crossrefType "journal-article" @default.
• W3119153085 hasAuthorship W3119153085A5002462389 @default.
• W3119153085 hasAuthorship W3119153085A5004594523 @default.
• W3119153085 hasAuthorship W3119153085A5007555318 @default.
• W3119153085 hasAuthorship W3119153085A5021628655 @default.
• W3119153085 hasAuthorship W3119153085A5029961005 @default.
• W3119153085 hasAuthorship W3119153085A5036153522 @default.
• W3119153085 hasAuthorship W3119153085A5038663308 @default.
• W3119153085 hasAuthorship W3119153085A5045732038 @default.
• W3119153085 hasAuthorship W3119153085A5049522204 @default.
• W3119153085 hasAuthorship W3119153085A5056313787 @default.

• next